Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer

NCT00859729 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: pVAXrcPSAv53l (DNA encoding rhesus PSA)
DEVICE: DERMA VAX™ intradermal DNA delivery system

Sponsor

Uppsala University

Collaborators

[object Object]
[object Object]